Exchange: NYSE·Updated 07:30 PM EDT

PHR News

News
all
press releases
Why Phreesia Stock Tumbled Today
Key PointsAlthough its net income rose sharply, analysts expected better...
Nasdaq News: Markets
More News
These Analysts Revise Their Forecasts On Phreesia After Q2 Results
Phreesia's Q2 EPS missed estimates, while sales beat. FY27 guidance held; shares fell 5.6%. Analysts kept bullish targets, Wells Fargo raised to $10.read more...
Benzinga
Phreesia (PHR) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates
The headline numbers for Phreesia (PHR) give insight into how the company performed in the quarter ended July 2026, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
Zacks
Transcript: Phreesia Q2 2027 Earnings Conference Call
Phreesia (NYSE:PHR) reported second-quarter financial results on Wednesday. The transcript from the company's second-quarter earnings call has been provided below. This content is powered by Benzinga APIs. Forread more...
Benzinga
Phreesia (PHR) Q2 Earnings and Revenues Lag Estimates
Phreesia (PHR) delivered earnings and revenue surprises of -72.73% and -0.13%, respectively, for the quarter ended July 2026. Do the numbers hold clues to what lies ahead for the stock?
Zacks
Phreesia Announces Second Quarter Fiscal 2027 Results
Phreesia, Inc. (NYSE: PHR) (Phreesia or the "Company") announced financial results today for the fiscal second quarter ended July 31, 2026. Phreesia delivered a solid fiscal second quarter, with revenue growth and profitability expansion in line with our expectations. We generated positive...
Business Wire
Veeva Systems (VEEV) Q2 Earnings and Revenues Beat Estimates
Veeva (VEEV) delivered earnings and revenue surprises of +5.86% and +2.64%, respectively, for the quarter ended July 2026. Do the numbers hold clues to what lies ahead for the stock?
Zacks
NRx Pharmaceuticals, Inc. (NRXP) Reports Q2 Loss, Misses Revenue Estimates
NRx Pharmaceuticals (NRXP) delivered earnings and revenue surprises of -100.00% and -54.13%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?
Zacks
ADC Therapeutics SA (ADCT) Reports Q2 Loss, Lags Revenue Estimates
ADC Therapeutics (ADCT) delivered earnings and revenue surprises of +42.11% and -4.48%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?
Zacks
Phreesia Sets Release Date for Fiscal Second Quarter 2027 Results
Phreesia, Inc. (NYSE: PHR) (Phreesia) today announced that it will release its fiscal second quarter 2027 financial results after the close of market trading on Wednesday, Sept. 2, 2026. Phreesia will issue a press release announcing its quarterly results and the companys quarterly stakeholder...
Business Wire

Advertisement|Remove ads.